ASCENDIS PHARMA A S's ticker is and the CUSIP is 04351P901. A total of 5 filers reported holding ASCENDIS PHARMA A S in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $644,000 | -22.8% | 50 | 0.0% | 0.02% | -22.6% |
Q4 2020 | $834,000 | -70.3% | 50 | -72.5% | 0.03% | -81.8% |
Q3 2020 | $2,809,000 | +4.3% | 182 | 0.0% | 0.17% | -7.6% |
Q2 2020 | $2,692,000 | +44.4% | 182 | +35.8% | 0.18% | +13.6% |
Q4 2019 | $1,864,000 | -5.1% | 134 | -34.3% | 0.16% | -10.0% |
Q3 2019 | $1,965,000 | -16.4% | 204 | 0.0% | 0.18% | -15.9% |
Q2 2019 | $2,350,000 | – | 204 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BOOTHBAY FUND MANAGEMENT, LLC | 50 | $834,000 | 0.03% |
JPMORGAN CHASE & CO | 27,000 | $4,503,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 19 | $316,000 | 0.00% |